Transdermal penetration of zalcitabine, lamivudine and synthesised N-acyl lamivudine esters

Int J Pharm. 2008 Mar 3;351(1-2):186-93. doi: 10.1016/j.ijpharm.2007.09.040. Epub 2007 Oct 6.

Abstract

The objective of this study was to determine the in vitro transdermal permeation through human epidermis of zalcitabine, lamivudine and the synthesised N-acyl lamivudine esters, with and without the use of Pheroid as delivery system and to establish a correlation, if any, with selected physicochemical properties. Six N-acyl lamivudine esters were prepared by acylation of lamivudine with six different acid chlorides. The experimental aqueous solubility, log D and in vitro transdermal flux values were determined for these compounds. There was an inverse correlation between the aqueous solubility and the log D values. The median flux of zalcitabine (0.442 micromol/cm2 h) in PBS was lower than that of lamivudine (4.289 micromol/cm2 h), but in Pheroid, lamivudine (0.011 micromol/cm2 h) had a slightly lower median flux than zalcitabine (0.015 micromol/cm2 h). Entrapment of compounds in Pheroid was confirmed by confocal laser scanning microscopy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Emulsions
  • Esters / chemical synthesis
  • Esters / pharmacokinetics*
  • Female
  • Humans
  • In Vitro Techniques
  • Lamivudine / chemistry
  • Lamivudine / pharmacokinetics*
  • Microscopy, Confocal
  • Reverse Transcriptase Inhibitors / chemical synthesis
  • Reverse Transcriptase Inhibitors / pharmacokinetics*
  • Skin
  • Skin Absorption
  • Solubility
  • Zalcitabine / pharmacokinetics*

Substances

  • Emulsions
  • Esters
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zalcitabine